UK's Syn­thace rais­es $35M in Se­ries C; On­col­o­gy and in­flam­ma­to­ry dis­ease biotech De­ka hauls in $20M Se­ries A

UK-based AI-as­sist­ed R&D biotech Syn­thace just wrapped up a Se­ries C round, bring­ing in $35 mil­lion.

Per a com­pa­ny state­ment this morn­ing, the in­vest­ment will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER